We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+2.2%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.12B
AUM Growth
-$54.3M
Cap. Flow
+$518K
Cap. Flow %
0.01%
Top 10 Hldgs %
6.44%
Holding
1,475
New
99
Increased
592
Reduced
300
Closed
114

Top Buys

Rank Stock Value
1
VIR icon
Vir Biotechnology
VIR
+$19.2M
2
ORCL icon
Oracle
ORCL
+$12.4M
3
CRGY icon
Crescent Energy
CRGY
+$11.4M
4
PARR icon
Par Pacific Holdings
PARR
+$11.1M
5
GPOR icon
Gulfport Energy Corp
GPOR
+$10.9M

Top Sells

Rank Stock Value
1
BCC icon
Boise Cascade
BCC
+$17.7M
2
THS
Treehouse Foods
THS
+$11.5M
3
TPH
Tri Pointe Homes
TPH
+$10.5M
4
STRL icon
Sterling Infrastructure
STRL
+$9.81M
5
TXN icon
Texas Instruments
TXN
+$9.45M

Sector Composition

Rank Sector Weight
1 Financials 25.32%
2 Consumer Discretionary 11.88%
3 Industrials 11.76%
4 Technology 10.68%
5 Energy 10.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
III icon
1126
Information Services Group
III
$251M
$182K ﹤0.01%
41,448
– –
SERA icon
1127
Sera Prognostics
SERA
$81.1M
$179K ﹤0.01%
96,105
+22,800
+31% +$54.5K
SGMO
1128
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$177K ﹤0.01%
+295,000
New +$316K
PXLW icon
1129
Pixelworks
PXLW
$41.6M
$176K ﹤0.01%
12,958
+341
+3% +$5.88K
SCYX icon
1130
SCYNEXIS
SCYX
$52M
$174K ﹤0.01%
9,563
– –
USIO icon
1131
Usio Inc
USIO
$64M
$169K ﹤0.01%
96,400
– –
AMTX icon
1132
Aemetis
AMTX
$124M
$166K ﹤0.01%
40,000
-50,000
-56% -$306K
MXC icon
1133
Mexco Energy
MXC
$19M
$164K ﹤0.01%
12,660
– –
SPRO icon
1134
Spero Therapeutics
SPRO
$73M
$163K ﹤0.01%
134,800
+25,000
+23% +$34.6K
CNTX icon
1135
Context Therapeutics
CNTX
$44.5M
$160K ﹤0.01%
105,809
– –
LUCD icon
1136
Lucid Diagnostics
LUCD
$184M
$158K ﹤0.01%
135,000
– –
HCWB icon
1137
HCW Biologics
HCWB
$5.45M
$158K ﹤0.01%
344
– –
ICAD
1138
DELISTED
iCAD Inc
ICAD
$157K ﹤0.01%
+74,600
New +$178K
LUMO
1139
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$157K ﹤0.01%
47,643
– –
SUNW
1140
DELISTED
Sunworks, Inc.
SUNW
$157K ﹤0.01%
302,073
– –
SYRS
1141
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$156K ﹤0.01%
39,500
– –
QNCX icon
1142
Quince Therapeutics
QNCX
$29.5M
$155K ﹤0.01%
692
+417
+152% +$109K
ASMB icon
1143
Assembly Biosciences
ASMB
$529M
$154K ﹤0.01%
14,500
– –
CRD.A icon
1144
Crawford & Co Class A
CRD.A
$669M
$154K ﹤0.01%
16,475
+474
+3% +$4.74K
CLSD
1145
DELISTED
Clearside Biomedical
CLSD
$153K ﹤0.01%
11,707
-6,933
-37% -$105K
FARM
1146
DELISTED
Farmer Brothers
FARM
$151K ﹤0.01%
58,700
-29,200
-33% -$76.4K
KORE
1147
DELISTED
KORE Group Holdings
KORE
$150K ﹤0.01%
49,740
-1,000
-2% -$4.7K
FEIM icon
1148
Frequency Electronics
FEIM
$816M
$149K ﹤0.01%
21,500
– –
GANX icon
1149
Gain Therapeutics
GANX
$77.6M
$149K ﹤0.01%
46,100
– –
RVP icon
1150
Retractable Technologies
RVP
$20.1M
$148K ﹤0.01%
124,534
+21,700
+21% +$25.5K
44 45
46
47 48

Similar funds

SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return

Bridgeway Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Bridgeway Capital Management held 1,475 positions worth $4.12B, down 1.3% from $4.18B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.

Bridgeway Capital Management's Q3 2023 filing shows 99 new, 592 increased, 300 reduced and 114 closed positions. Its largest new stake was Vir Biotechnology: 1,345,635 shares worth $12.6M. The largest sale was Boise Cascade, an estimated $17.7M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bridgeway Capital Management's largest Q3 2023 buy was Vir Biotechnology: 1,345,635 shares worth $12.6M.
  • Bridgeway Capital Management added most to Oracle in Q3 2023, an estimated $12.4M increase.
  • Bridgeway Capital Management's biggest Q3 2023 reduction was Boise Cascade, cutting an estimated $17.7M.
  • Bridgeway Capital Management fully exited Treehouse Foods in Q3 2023, selling an estimated $11.5M.
  • Bridgeway Capital Management's ten largest holdings make up 6.4% of its $4.12B portfolio in Q3 2023.
  • Bridgeway Capital Management opened 99 new positions and closed 114 in Q3 2023.
  • Bridgeway Capital Management's portfolio value fell 1.3% quarter-over-quarter to $4.12B.

Based on Bridgeway Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.